Register Login
Register to leave comments
  • News bot Jan. 31, 2026, 10:19 a.m.

    📋 Moleculin Biotech Inc. (MBRX) - Clinical Trial Update

    Filing Date: 2026-01-13

    Accepted: 2026-01-13 08:55:12

    Event Type: Clinical Trial Update

    Event Details:

    Moleculin Biotech Inc. (MBRX) Announces Clinical Trial Update Moleculin Biotech Inc. (MBRX) provided an update on its clinical development programs. Clinical Development Highlights:
    • Drug Program: maximum, cardiotoxicity
    • Diseases/Conditions: treating multiple oncology indications HOUSTON, assessing cardiotoxicity
    • Clinical Stage: clinical trial
    • Collaboration: AML
      • targeting brain tumors, pancreatic and other cancers. Moleculin also has in its pipeline a portfolio of antimetabolites, including WP1122

    🔬 Clinical Development Pipeline (Moleculin Biotech Inc.):

    Product Type Development Stage Therapeutic Area Source
    Liposomal Annamycin for Injection in combination with Cytarabine Injection. DRUG Phase PHASE2 Acute Myeloid Leukaemia (AML) ClinicalTrials.gov
    WP1122 DRUG Phase PHASE1 Healthy Volunteer ClinicalTrials.gov
    Surgical Procedure PROCEDURE Phase PHASE2 Glioblastoma, IDH-Wildtype ClinicalTrials.gov
    STAT3 Inhibitor WP1066 DRUG Phase PHASE2 Glioblastoma, IDH-Wildtype ClinicalTrials.gov
    Radiation Therapy RADIATION Phase PHASE2 Glioblastoma, IDH-Wildtype ClinicalTrials.gov
    Magnetic Resonance Imaging PROCEDURE Phase PHASE2 Glioblastoma, IDH-Wildtype ClinicalTrials.gov
    Biospecimen Collection PROCEDURE Phase PHASE2 Glioblastoma, IDH-Wildtype ClinicalTrials.gov
    Liposomal Annamycin Injection in combination with Cytarabine Injection DRUG Phase PHASE2 Acute Myeloid Leukaemia (AML) ClinicalTrials.gov
    Placebo in combination with Cytarabine Injection DRUG Phase PHASE2 Acute Myeloid Leukaemia (AML) ClinicalTrials.gov
    Cytarabine DRUG Phase PHASE1 Leukemia, Myeloid, Acute ClinicalTrials.gov
    Liposomal Annamycin DRUG Phase PHASE1 Leukemia, Myeloid, Acute ClinicalTrials.gov
    WP1220 DRUG Phase PHASE1 Cutaneous T-Cell Lymphoma/Mycosis Fungoides ClinicalTrials.gov
    Placebo DRUG Phase PHASE1 Healthy Volunteer ClinicalTrials.gov
    Liposomal Annamycin (L-Annamycin) DRUG Phase PHASE1 Sarcoma,Soft Tissue ClinicalTrials.gov

    💼 Business Developments:

    • Partnership: Not available
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: Moleculin Biotech Inc.
    • Ticker Symbol: MBRX

Search

News categories